Cita APA (7a ed.)
E, B., M, A., PH, N., PM, S., Berge, E., Abdelnoor, M., . . . Sandset, P. M. (2000). Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: A double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial. Lancet, 355(9211), 1205-1211.
Cita Chicago Style (17a ed.)
E, Berge, Abdelnoor M, Nakstad PH, Sandset PM, E. Berge, M. Abdelnoor, P H. Nakstad, y P M. Sandset. "Low Molecular-weight Heparin Versus Aspirin in Patients with Acute Ischaemic Stroke and Atrial Fibrillation: A Double-blind Randomised Study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial." Lancet 355, no. 9211 (2000): 1205-1211.
Cita MLA (9a ed.)
E, Berge, et al. "Low Molecular-weight Heparin Versus Aspirin in Patients with Acute Ischaemic Stroke and Atrial Fibrillation: A Double-blind Randomised Study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial." Lancet, vol. 355, no. 9211, 2000, pp. 1205-1211.
Precaución: Estas citas no son 100% exactas.